Aker BioMarine Balance Sheet Health
Financial Health criteria checks 4/6
Aker BioMarine has a total shareholder equity of $354.7M and total debt of $395.3M, which brings its debt-to-equity ratio to 111.4%. Its total assets and total liabilities are $813.5M and $458.8M respectively. Aker BioMarine's EBIT is $9.6M making its interest coverage ratio 0.3. It has cash and short-term investments of $32.0M.
Key information
111.4%
Debt to equity ratio
US$395.30m
Debt
Interest coverage ratio | 0.3x |
Cash | US$32.00m |
Equity | US$354.70m |
Total liabilities | US$458.80m |
Total assets | US$813.50m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1PG's short term assets ($288.6M) exceed its short term liabilities ($113.5M).
Long Term Liabilities: 1PG's short term assets ($288.6M) do not cover its long term liabilities ($345.3M).
Debt to Equity History and Analysis
Debt Level: 1PG's net debt to equity ratio (102.4%) is considered high.
Reducing Debt: 1PG's debt to equity ratio has reduced from 149.5% to 111.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 1PG has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 1PG is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 24.9% per year.